Endothelial dysfunction in diabetes

British Journal of Pharmacology

Volumn 130, Issue 5, 2000, Pages 963-974

  De Vriese, An S ^b   Verbeuren, Tony J ^a   Van De Voorde, Johan ^c   Lameire, Norbert H ^c   Vanhoutte, Paul M ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c NONE

Author keywords

Advanced glycation end products; Aldose reductase; Diabetes; Endothelial dysfunction; Endothelium dependent vasodilation; Endothelium derived hyperpolarizing factor; Nitric oxide; Oxidative stress; Protein kinase C

Indexed keywords

ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE; POLYOL; PROSTACYCLIN; PROTEIN KINASE C; VASODILATOR AGENT;

DIABETES MELLITUS; GLYCATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0033920419     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703393     Document Type: Review

References (115)

1. ANDERSON, T.J. (1999). Assessment and treatment of endothelial dysfunction in humans. J. Am. Coll. Cardiol., 34, 631-638.
2. ANGULO, J., RODRIGUEZ-MANAS, L., PEIRO, C., NEIRA, M., MARIN, J. & SANCHEZ-FERRER, C.F. (1998). Impairment of nitric oxide-mediated relaxations in anaesthetized autoperfused streptozotocin-induced diabetic rats. Naunyn Schmiedeberg's Arch. Pharmacol., 358, 529-537.
3. ARCARO, G., ZENERE, B.M., SAGGIANI, F., ZENTI, M.G., MONAUNI, T., LECHI, A., MUGGED, M. & BONADONNA, R.C. (1999). ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care, 22, 1536-1542.
4. BAYNES, J.W. & THORPE, S.R. (1999). Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes, 48, 1-9.
5. BHARDWAJ, R. & MOORE, P.K. (1988). Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J. Pharm. Pharmacol., 40, 739-742.
6. BIJLSTRA, P.J., SMITS, P., LUTTERMAN, J.A. & THIEN, T. (1995). Effect of long-term angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndrome. J. Cardiovasc. Pharmacol., 25, 658-664.
7. BOHLEN, H.G. & LASH, J.M. (1993). Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. Am. J. Physiol., 265, H219-H225.
8. BOHLEN, H.G. & LASH, J.M. (1995). Endothelium-dependent vasodilation is preserved in non-insulin-dependent Zucker fatty diabetic rats. Am. J. Physiol., 268, H2366-H2374.
9. BUCALA, R., TRACEY, K.J. & CERAMI, A. (1991). Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J. Clin. Invest., 87, 432-438.
10. CALVER, A., COLLIER, J. & VALLANCE, P. (1992). Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J. Clin. Invest., 90, 2548-2554.
11. CAMERON, N.E. & COTTER, M.A. (1992). Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia, 35, 1011-1019.
12. CERIELLO A. (1999). Hyperglycemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications. Diabetes Nutr. Metab., 12, 42-46.
13. CLARKSON, P., CELERMAJER, D.S., DONALD, A.E., SAMPSON, M., SORENSEN, K.E., ADAMS, M., YUE, D.K., BETTERIDGE D.J. & DEANFIELD, J.E. (1996). Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J. Am. Coll. Cardiol., 28, 573-579.
14. COSTA E FORTI, A. & FONTELES, M.C. (1998). Decreased endothelium dependent relaxation (nitric oxide) in diabetic kidneys. Horm. Metab. Res., 30, 55-57.
15. CRAVEN, P.A., STUDER, R.K., NEGRETE, H. & DERUBERTIS, F.R. (1995). Protein kinase C in diabetic nephropathy. J. Diabetes Complic., 9, 241-245.
16. CRIJNS, F.R., STRUIJKER BOUDIER, H.A. & WOLFFENBUTTEL, B.H. (1998). Arteriolar reactivity in conscious diabetic rats. Influence of aminoguanidine treatment. Diabetes, 47, 918-923.
17. DAI, F., DIEDERICH, A., SKOPEC, J. & DIEDERICH, D. (1993). Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals. J. Am. Soc. Nephrol., 4, 1327-1336.
18. DE VRIESE, A., VAN DE VOORDE, J., VANHOLDER, R. & LAMEIRE, N. (1999). Impaired endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response in diabetes: restoration with folate. J. Am. Soc. Nephrol., 10, 394A.
19. DIEDERICH, D., SKOPEC, J., DIEDERICH, A. & DAI, F. (1994). Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am. J. Physiol., 266, H1153-H1161.
20. DURANTE, W., SEN, A.K. & SUNAHARA, F.A. (1988). Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. Br. J. Pharmacol., 94, 463-468.
21. ENDERLE, M.D., BENDA, N., SCHMUELLING, R.M., HAERING, H.U. & PFOHL, M. (1998). Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects. Diabetes Care, 21, 271-277.
22. ENDO, K., ABIRU, T., MACHIDA, H., KASUYA, Y. & KAMATA, K. (1995). Endothelium-derived hyperpolarizing factor does not contribute to the decrease in endothelium-dependent relaxation in the aorta of streptozotocin-induced diabetic rats. Gen. Pharmacol., 26, 149-153.
23. FÉLÉTOU, M. & VANHOUTTE, P.M. (1999). The alternative: EDHF. J. Moll. Cell. Cardiol., 31, 15-22.
24. FORTES, Z.B., LEME, J.G. & SCIVOLETTO, R. (1983). Vascular reactivity in diabetes mellitus: role of the endothelial cell. Br. J. Pharmacol., 79, 771-781.
25. FRIEDMAN, E.A. (1999). Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care, 22 (Suppl 2), B65-B71.
26. FUKAO, M., HATTORI, Y., KANNO, M, SAKUMA, I. & KITABATAKE, A. (1997). Alterations in endothelium-dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin-induced diabetic rats. Br. J. Pharmacol., 121, 1383-1391.
27. FULTON, D., MCGIFF, J.C. & QUILLEY, J. (1996). Cytochrome P450 arachidonate metabolites: deficit in diabetes mellitus? FASEB J., 9, A113.
28. FURCHGOTT, R.F. & VANHOUTTE, P.M. (1989). Endothelium-derived relaxing and contracting factors. FASEB J., 3, 2007-2018.
29. GABBAY, K.H. (1973). The sorbitol pathway and the complications of diabetes. N. Engl. J. Med., 288, 831-836.
30. GAZIS, A., WHITE, D.J., PAGE, S.R. & COCKCROFT, J.R. (1999). Effect of oral vitamin E (α-tocopherol) supplementation on vascular endothelial function in type 2 diabetes mellitus. Diabet. Med., 16, 304-311.
31. GEBREMEDHIN, D., KOLTAI, M.Z., POGATSA, G., MAGYAR, K. & HADHAZY, P. (1988). Influence of experimental diabetes on the mechanical responses of canine coronary arteries: role of endothelium. Cardiovasc. Res., 22, 537-544.
32. GIUGLIANO, D., CERIELLO, A. & PAOLISSO, G. (1996). Oxidative stress and diabetic vascular complications. Diabetes Care, 19, 257-267.
33. HATTORI, Y., KAWASAKI, H., ABE, K. & KANNO, M. (1991). Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol., 261, H1086-H1094.
34. HEAD, R.J., LONGHURST, P.A., PANEK, R.L. & STITZEL, R.E. (1987). A contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit. Br. J. Pharmacol., 91, 275-286.
35. HEYGATE, K.M., LAWRENCE, I.G., BENNETT, M.A. & THURSTON, H. (1995). Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br. J. Pharmacol., 116, 3251-3259.
36. HILL, M.A. & EGE, E.A. (1994). Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats. Effect of aminoguanidine treatment. Diabetes, 43, 1450-1456.
37. HUIJBERTS, M.S., WOLFFENBUTTEL, B.H., STRUIJKER BOUDIER, H.A., CRIJNS, F.R., NIEWENHUIJZEN KRUSEMAN, A.C., POITEVIN, P. & LÉVY, B.I. (1993). Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J. Clin. Invest., 92, 1407-1411.
38. JOHNSTONE, M.T., CREAGER, S.J., SCALES, K.M., CUSCO, J.A., LEE, B.K. & CREAGER, M.A. (1993). Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation, 88, 2510-2516.
39. JORGENSEN, R.G., RUSSO, L., MATTIOLI, L. & MOORE, W.V. (1988). Early detection of vascular dysfunction in type I diabetes. Diabetes, 37, 292-296.
40. KATUSIC, Z.S. & VANHOUTTE, P.M. (1989). Superoxide anion is an endothelium-derived contracting factor. Am. J. Physiol., 257, H33-H37.
41. KHAN, F., COHEN, R.A., RUDERMAN, N.B., CHIPKIN, S.R. & COFFMAN, J.D. (1996). Vasodilator responses in the forearm skin of patients with insulin-dependent diabetes mellitus. Vasc. Med., 1, 187-193.
42. KEEGAN, A., WALBANK, H., COTTER, M.A. & CAMERON, N.E. (1995). Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia, 38, 1475-1478.
43. KIFF, R.J., GARDINER, S.M., COMPTON, A.M. & BENNETT, T. (1991). Selective impairment of hindquarters vasodilator responses to bradykinin in conscious wistar rats with streptozotocin-induced diabetes mellitus. Br. J. Pharmacol., 103, 1357-1362.
44. KOLTAI, M.Z., HADHAZY, P., POSA, I., KOCSIS, E., WINKLER, G., ROSEN, P. & POGATSA, G. (1997). Characteristics of coronary endothelial dysfunction in experimental diabetes. Cardiovasc. Res., 34, 157-163.
45. KONTOS, H.A. (1987). Oxygen radicals from arachidonate metabolism in abnormal vascular responses. Am. Rev. Respir. Dis., 136, 474-477.
46. KOYA, D. & KING, G.L. (1998). Protein kinase C activation and the development of diabetic complications. Diabetes, 47, 859-866.
47. KUNISAKI, M., BURSELL, S.E., CLERMONT, A.C., ISHII, H., BALLAS, L.M., JIROUSEK, M.R., UMEDA, F., NAWATA, H. & KING, G.L. (1995). Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am. J. Physiol., 269, E239-E246.
48. LAMBERT, J., AARSEN, M., DONKER, A.J. & STEHOUWER, C.D. (1996). Endothelium-dependent and independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. Arterioscler. Thromb. Vasc. Biol., 16, 705-711.
49. LASH, J.M. & BOHLEN, H.G. (1991). Structural and functional origins of suppressed acetylcholine vasodilation in diabetic rat arterioles. Circ. Res., 69, 1259-1268.
50. LEKAKIS, J., PAPAMICHAEL, C., ANASTASIOU, H., ALEVIZAKI, M., DESSES, N., SOUVATZOGLOU, A., STAMATELOPOULOS, S. & KOUTRAS, D.A. (1997). Endothelial dysfunction of conduit arteries in insulin-dependent diabetes mellitus without micro-albuminuria. Cardiovasc. Res., 34, 164-168.
51. MACALLISTER, R.J., CALVER, A.L., COLLIER, J., EDWARDS, M.B., HERREROS, B., NUSSEY, S.S. & VALEANCE, P. (1995). Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect. Clin. Sci., 89, 183-190.
52. MATSUNAGA, T., OKUMURA, K., ISHIZAKA, H., TSUNODA, R., TAYAMA, S., TABUCHI, T. & YASUE, H. (1996). Impairment of coronary blood flow regulation by endothelium-derived nitric oxide in dogs with alloxan-induced diabetes. J. Cardiovasc. Pharmacol., 28, 60-67.
53. MAYHAN, W.G. (1997). Superoxide dismutase partially restores impaired dilatation of the basilar artery during diabetes mellitus. Brain. Res., 760, 204-209.
54. MAYHAN, W.G. & FARACI, F.M. (1993). Responses of cerebral arterioles in diabetic rats to activation of ATP-sensitive potassium channels. Am. J. Physiol., 265, H152-H157.
55. MAYHAN, W.G. & PATEL, K.P. (1995). Acute effects of glucose on reactivity of cerebral microcirculation: role of activation of protein kinase C. Am. J. Physiol., 269, H1297-H1302.
56. MAYHAN, W.G. & PATEL, K.P. (1998). Treatment with dimethylthiourea prevents impaired dilation of the basilar artery during diabetes mellitus. Am. J. Physiol., 274, H1895-H1901.
57. MAYHAN, W.G., PATEL, K.P. & SHARPE, G.M. (1997). Effect of Larginine on reactivity of hamster cheek pouch arterioles during diabetes mellitus. Int. J. Microcirc., 17, 107-112.
58. MAYHAN, W.G., SIMMONS, L.K. & SHARPE, G.M. (1991). Mechanisms of impaired responses of cerebral arterioles during diabetes mellitus. Am. J. Physiol., 260, H319-H326.
59. MCFARLANE, R., MCCREDIE, R.J., BONNEY, M., MOLYNEAUX, L., ZILKENS, R., CELERMAJER, D.S. & YUE, D.K. (1999). Angiotensin converting enzyme inhibition and arterial endothelial function in adults with type 1 diabetes mellitus. Diabel. Med., 16, 62-66.
60. MCNALLY, P.G., WATT, P.A., RIMMER, T., BURDEN, A.C., HEARNSHAW, J.R. & THURSTON, H. (1994). Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. Clin. Sci., 87, 31-36.
61. MCVEIGH, G.E., BRENNAN, G.M., JOHNSTON, G.D., MCDERMOTT, B.J., MCGRATH, L.T., HENRY, W.R. & ANDREWS, J.W. (1992). Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 35, 771-776.
62. MCVEIGH, G.E., BRENNAN, G.M., JOHNSTON, G.D., MCDERMOTT, B.J., MCGRATH, L.T., HENRY, W.R., ANDREWS, J.W. & HAYES, J.R. (1993). Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 36, 33-38.
63. MIYATA, T., VAN YPERSELE DE STRIHOU, C., KUROKAWA, K. & BAYNES, J.W. (1999). Alterations in nonenzymatic biochemistry in uremia: origin and significance of 'carbonyl stress' in long-term uremic complications. Kidney Int., 55, 389-399.
64. MOMBOULI, J.V. & VANHOUTTE, P.M. (1997). Endothelium-derived hyperpolarizing factor(s): updating the unknown. Trends Pharmacol. Sci., 18, 252-256.
65. MULHERN, M. & DOCHERTY, J.R. (1989). Effects of experimental diabetes on the responsiveness of rat aorta. Br. J. Pharmacol., 97, 1007-1012.
66. MULLEN, M.J., CLARKSON, P., DONALD, A.E., THOMSON, H., THORNE, S.A., POWE, A.J., FURUNO, T., BULL, T. & DEANFIELD, J.E. (1998). Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized double-blind study. J. Am. Coll. Cardiol., 31, 1330-1335.
67. NITENBERG, A., VALENSI, P., SACHS, R., DALI, M., APTECAR, E. & ATTALI, J. (1993). Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes, 42, 1017-1025.
68. O'DRISCOLL, G., GREEN, D., MAIORANA, A., STANTON, K., COLREAVY, F. & TAYLOR, R. (1999). Improvement in endothelial function by angiotensin converting enzyme inhibition in non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol., 33, 1506-1511.
69. O'DRISCOLL, G., GREEN, D., RANKIN, J., STANTON, K. & TAYLOR, R. (1997). Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J. Clin. Invest., 100, 678-684.
70. OTTER, D.J. & CHESS-WILLIAMS, R. (1994). The effects of aldose reductase inhibition with ponalrestat on changes in vascular function in streptozotocin diabetic rats. Br. J. Pharmacol., 113, 576-580.
71. OYAMA, Y., KAWASAKI, H., HATTORI, Y. & KANNO, M. (1986). Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur. J. Pharmacol., 131, 75-78.
72. PALMER, A.M., GOPAUL, N., DHIR, S., THOMAS, C.R., POSTON, L. & TRIBE, R.M. (1998b). Endothelial dysfunction in streptozotocin-diabetic rats is not reversed by dietary probucol or simvastatin supplementation. Diabetologia, 41, 157-164.
73. PALMER, A.M., THOMAS, C.R., GOPAUL, N., DHIR, S., ÄNGGARD, E.E., POSTON, L. & TRIBE, R.M. (1998a). Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocin-diabetic rat. Diabetologia, 41, 148-156.
74. PELLIGRINO, D.A., KOENIG, H.M., WANG, Q. & ALBRECHT, R.F. (1994). Protein kinase C suppresses receptor-mediated pial arteriolar relaxation in the diabetic rat. Neuro Report, 5, 417-420.
75. PERICO, N. & REMUZZI, G. (1999). Diabetic nephropathy: animal models of human type 2 diabetes. In Nephropathy in type 2 diabetes. ed. Ritz, E. & Rychlik, I. pp. 47-57. New York: Oxford University Press.
76. PFEIFER, M.A., SCHUMER, M.P., GELBER, D.A. (1997). Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes, 46 (Suppl. 2), S82-S89.
77. PIEPER, G.M., ADAMS, M.B. & ROZA, A.M. (1998a). Pancreatic transplantation reverses endothelial dysfunction in experimental diabetes mellitus. Surgery, 123, 89-95.
78. PIEPER, G.M. & GROSS, G.J. (1988). Oxygen free radicals abolish endothelium-dependent relaxation in diabetic aorta. Am. J. Physiol., 255, H825-H833.
79. PIEPER, G.M., LANGENSTROER, P. & SIEBENEICH, W. (1997). Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc. Res., 34, 145-156.
80. PIEPER, G.M., MEI, D.A., LANGENSTROER, P. & O'ROURKE, S.T. (1992). Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am. J. Physiol., 263, H676-H680.
81. PIEPER, G.M., MOORE-HILTON, G. & ROZA, A.M. (1996). Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. Life Sci., 58, 147-152.
82. PIEPER, G.M. & PELTIER, B.A. (1995). Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J. Cardiovasc. Pharmacol., 25, 397-403.
83. PIEPER, G.M. & SIEBENEICH, W. (1998b). Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J. Cardiovasc. Pharmacol., 32, 101-105.
84. QUILLEY, J., MCGIFF, J.C., MIEYAL, P., RAPACON, M. & FULTON, D. (1996). NO-independent coronary vasodilation to bradykinin in diabetes. Hypertension, 28, P178.
85. RÖSEN, P., BALLHAUSEN, T. & STOCKKLAUSER, K. (1996). Impairment of endothelium dependent relaxation in the diabetic rat heart: mechanisms and implications. Diabetes Res. Clin. Pr., 31, S143-S155.
86. RUBANYI, G.M. & VANHOUTTE, P.M. (1986). Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol., 250, H822-H827.
87. SAKAMOTO, S., MINAMI, K., NIWA, Y., OHNAKA, M., NAKAYA, Y., MIZUNO, A., KUWAJIMA, M. & SHIMA, K. (1998). Effect of exercise training and food restriction on endothelium-dependent relaxation in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous NIDDM. Diabetes, 47, 82-86.
88. SCHMIDT, A.M., YAN, S.D., WAUTIER, J.L. & STERN, D. (1999). Activation of receptor for advanced glycation end products. A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res., 84, 489-497.
89. SHIBANO, T. & VANHOUTTE, P.M. (1994). Involvement of 5-HT2 receptors in chronic endothelial dysfunction after balloon injury of porcine coronary arteries. Circulation, 89, 1776-1785.
90. 2 as an endothelial-derived contracting factor in diabetic state. Diabetes, 42, 1246-1252.
91. SMITS, P., KAPMA, J., JACOBS, M., LUTTERMAN, J. & THIEN, T. (1993). Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes, 42, 148-153.
92. SOBREVIA, L. & MANN, G.E. (1997). Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia. Exp. Physiol., 82, 423-452.
93. TAYLOR, P.D., GRAVES, J.E. & POSTON, L. (1995). Selective impairment of acetylcholine-mediated endothelium-dependent relaxation in isolated resistance arteries of streptozotocin-induced diabetic rat. Clin. Sci., 88, 519-524.
94. TAYLOR, P.D., MCCARTHY, A.L., THOMAS, C.R. & POSTON, L. (1992). Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin-induced diabetic rats. Br. J. Pharmacol., 107, 393-399.
95. TAYLOR, P.D., OON, B.B., THOMAS, C.R. & POSTON, L. (1994a). Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenaline-induced contractility in mesenteric resistance arteries from streptozotocin-induced diabetic rats. Br. J. Pharmacol., 111, 35-41.
96. TAYLOR, P.D., WICKENDEN, A.D., MIRRLEES, D.J. & POSTON, L. (1994b). Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat. Br. J. Pharmacol., 111, 42-48.
97. TESFAMARIAM, B., BROWN, M.L. & COHEN, R.A. (1991). Elevated glucose impairs endothelium-dependent relaxation by activating protein kinasr C. J. Clin. Invest., 87, 1643-1648.
98. TESFAMARIAM, B., BROWN, M.L., DEYKIN, D. & COHEN, R.A. (1990). Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J. Clin. Invest., 85, 929-932.
99. TESFAMARIAM, B.& COHEN, R.A. (1992). Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol., 263, H321-H326.
100. 2. Am. J. Physiol., 257, H1327-H1333.
101. TESFAMARIAM, B., PALACINO, J.J., WEISBROD, R.M. & COHEN, R.A. (1993). Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J. Cardiovasc. Pharmacol., 21, 205-211.
102. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP/EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS RESEARCH GROUP (2000). Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Eng. J. Med., 342, 381-389.
103. TILTON, R.G., CHANG, K., HASAN, K.S., SMITH, S.R., PETRASH, J.M., MISKO, T.P., MOORE, W.M., CURRIE, M.G., CORBETT, J.A., MCDANIEL, M.L. & WILLIAMSON, J.R. (1993). Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes, 42, 221-232.
104. TING, H.H., TIMIMI, F.K., BOLES, K.S., CREAGER, S.J., GANZ, P. & CREAGER, M.A. (1996). Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest., 97, 22-28.
105. USUI, M., MATSUOKA, H., MIYAZAKI, H., UEDA, S., OKUDA, S. & IMAIZUMI, T. (1999). Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid. Clin. Sci., 96, 235-239.
106. VANHOUTTE, P.M., BOULANGER, C.M. & MOMBOULI, J.V. (1995). Endothelium-derived relaxing factors and converting enzyme inhibition. Am. J. Cardiol., 76, 3E-12E.
107. VERHAAR, M.C., WEVER, R.M., KASTELEIN, J.J., VAN LOON, D., MILSTIEN, S., KOOMANS, H.A. & RABELINK, T.J. (1999). Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia: a randomized placebo-controlled trial. Circulation, 100, 335-338.
108. WAKABAYASHI, I., HATAKE, K., KIMURA, N., KAKISHITA, E. & NAGAI, K. (1987). Modulation of vascular tonus by the endothelium in experimental diabetes. Life Sci., 40, 643-648.
109. WANG, Y., BROOKS, D.P. & EDWARDS, R.M. (1993). Attenuated glomerular cGMP production and renal vasodilation in strepto-zotocin-induced diabetic rats. Am. J. Physiol., 264, R952-R956.
110. WHITE, R.E. & CARRIER, G.O. (1986). Supersensitivity and endothelium dependency of histamine-induced relaxation in mesenteric arteries of diabetic rats. Pharmacology, 33, 34-38.
111. WILLIAMS, S.B., CUSCO, J.A., RODDY M., JOHNSTONE, M.T., CREAGER, M.A. (1996). Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol., 27, 567-574.
112. WOLFF, S.P. & DEAN, R.T. (1987). Glucose automation and protein modification. The potential role of oxidative glycosylation in diabetes. Biochem. J., 245, 243-250.
113. YAN, S.D., SCHMIDT, A.M., ANDERSON, G.M., ZHANG, J., BRETT, J., ZOU, Y.S., PINSKY, D. & STERN, D. (1994). Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Cell. Biol., 269, 9889-9897.
114. ZENERE, B.M., ARCARO, G., SAGGIANI, F., ROSSI, L., MUGGEO, M. & LECHI, A. (1995). Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care, 18, 975-982.
115. ZENON, G.J., ABOBO, C.V., CARTER, B.L. & BALL, D.W. (1990). Potential use of aldose reductase inhibitors to prevent diabetic complications. Clin. Pharm., 9, 446-457.